These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12615603

  • 1. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC, Kreiss K, Andrew M, Weston A.
    Am J Epidemiol; 2003 Mar 01; 157(5):388-98. PubMed ID: 12615603
    [Abstract] [Full Text] [Related]

  • 2. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.
    Am J Ind Med; 2004 Aug 01; 46(2):95-103. PubMed ID: 15273960
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.
    J Immunol; 1999 Aug 01; 163(3):1647-53. PubMed ID: 10415070
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
    Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA.
    Tissue Antigens; 2007 Dec 01; 70(6):480-6. PubMed ID: 17927685
    [Abstract] [Full Text] [Related]

  • 7. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
    Richeldi L, Sorrentino R, Saltini C.
    Science; 1993 Oct 08; 262(5131):242-4. PubMed ID: 8105536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beryllium sensitivity is linked to HLA-DP genotype.
    Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL.
    Toxicology; 2001 Aug 13; 165(1):27-38. PubMed ID: 11551429
    [Abstract] [Full Text] [Related]

  • 10. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P, Amicosante M, Berretta F, Dotti C, Bocchino M, O'Donnell KM, Saltini C.
    Int J Immunopathol Pharmacol; 2004 Aug 13; 17(2 Suppl):3-10. PubMed ID: 15345185
    [Abstract] [Full Text] [Related]

  • 11. Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.
    Silver K, Sharp RR.
    J Occup Environ Med; 2006 Apr 13; 48(4):434-43. PubMed ID: 16607200
    [Abstract] [Full Text] [Related]

  • 12. Genetic determinants of sensitivity to beryllium in mice.
    Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.
    J Immunotoxicol; 2009 Jun 13; 6(2):130-5. PubMed ID: 19589099
    [Abstract] [Full Text] [Related]

  • 13. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.
    Occup Environ Med; 2011 Jul 13; 68(7):487-93. PubMed ID: 21186201
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.
    Eur Respir J; 2001 Oct 13; 18(4):677-84. PubMed ID: 11716174
    [Abstract] [Full Text] [Related]

  • 16. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model.
    Saltini C, Amicosante M, Franchi A, Lombardi G, Richeldi L.
    Eur Respir J; 1998 Dec 13; 12(6):1463-75. PubMed ID: 9877510
    [Abstract] [Full Text] [Related]

  • 17. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
    Maier L, Martyny J, Mroz M, McGrath D, Lympany P, duBois R, Zhang L, Murphy J, Newman LS.
    Chest; 2002 Mar 13; 121(3 Suppl):81S. PubMed ID: 11893702
    [No Abstract] [Full Text] [Related]

  • 18. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
    Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.
    J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315
    [Abstract] [Full Text] [Related]

  • 19. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.
    Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1680-8. PubMed ID: 21471109
    [Abstract] [Full Text] [Related]

  • 20. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
    Crooks J, Mroz MM, VanDyke M, McGrath A, Schuler C, McCanlies EC, Virji MA, Rosenman KD, Rossman M, Rice C, Monos D, Fingerlin TE, Maier LA.
    Occup Environ Med; 2022 Feb 15; 79(2):120-126. PubMed ID: 34535537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.